Fenbendazole 222 mg tablets are a widely used anthelmintic (anti-parasitic) medication, primarily formulated to treat gastrointestinal parasites in animals. Recently, however, these tablets have gained attention for their potential off-label applications in humans, especially in alternative cancer treatment discussions.
Fenbendazole works by disrupting the energy metabolism of parasites. It binds to tubulin proteins in their cells, inhibiting microtubule formation. This action prevents parasites from absorbing glucose, effectively starving and killing them. The 222 mg dosage is particularly popular due to its manageable strength, making it easier to administer in smaller animals—or in precise, low-dose experimental use under strict supervision.
While Fenbendazole is approved for veterinary use, interest in its possible role in human health—particularly for cancer support—has led many to explore it cautiously. However, it’s important to note that Fenbendazole 222 mg tablets are not FDA-approved for human use, and any off-label application should be done under medical supervision.
When sourcing this medication, always choose a reliable Fenbendazole 222 mg manufacturer to ensure product safety, consistency, and quality. Reputable manufacturers provide lab-tested, GMP-certified products, reducing the risk of contamination or dosage inaccuracies.
